Atlas Trials

Post-Approval Safety Monitoring Program to Assess the Safety Profile of GARDASIL in China Usual Practice

Clinical trial NCT03659110 · UNKNOWN

Trial details

NCT number
NCT03659110
Sponsor
Beijing Chaoyang District Centre for Disease Control and Prevention
Status
UNKNOWN
Study type
OBSERVATIONAL
Cervical Cancer
Start date
2018-10-01
Primary completion
2021-07-30
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.